Title:
ＩＲＡＫ４阻害剤、及びその応用
Document Type and Number:
Japanese Patent JP6851367
Kind Code:
B2
Abstract:
The present invention relates to a compound inhibiting the activity of an IRAK4 kinase, a pharmaceutical composition thereof, a use thereof in preparing drugs, a method in which same is used for inhibiting the activity of the IRAK4 kinase and a method in which same is used for treating and/or preventing IRAK4 kinase mediated diseases or conditions in mammals (particularly humans). The compound has a structural formula I .
Inventors:
Xue Jewel
Chung Thou
Car Biei
Kim Meng Yan
Chung Thou
Car Biei
Kim Meng Yan
Application Number:
JP2018507537A
Publication Date:
March 31, 2021
Filing Date:
August 13, 2015
Export Citation:
Assignee:
BEIJING HANMI PHARM. CO., LTD.
International Classes:
C07D495/04; A61K31/519; A61K31/5377; A61K45/00; A61P1/04; A61P7/00; A61P7/02; A61P11/00; A61P17/06; A61P19/00; A61P19/02; A61P25/00; A61P29/00; A61P35/00; A61P35/02; A61P37/02; A61P43/00
Domestic Patent References:
| JP2008013527A | ||||
| JP2013539762A | ||||
| JP2011518219A | ||||
| JP2018514559A |
Foreign References:
| WO2015048281A1 | ||||
| WO2014011911A2 | ||||
| WO2006105056A2 | ||||
| WO2015039612A1 |
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe